UnitedHealth Group (NYSE:UNH) had its price objective lifted by research analysts at Argus to $270.00 in a note issued to investors on Thursday. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Argus’ price target would suggest a potential upside of 10.95% from the company’s previous close.

Other analysts have also issued reports about the company. Deutsche Bank raised their target price on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. Piper Jaffray Companies reiterated a “buy” rating and issued a $259.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Finally, Citigroup lifted their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $243.22.

Shares of UnitedHealth Group (NYSE:UNH) traded up $0.19 during trading hours on Thursday, hitting $243.35. The stock had a trading volume of 4,289,381 shares, compared to its average volume of 3,010,000. UnitedHealth Group has a 52 week low of $156.49 and a 52 week high of $244.35. The firm has a market capitalization of $235,290.00, a price-to-earnings ratio of 22.72, a PEG ratio of 1.42 and a beta of 0.66. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same period last year, the company posted $2.11 earnings per share. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. analysts predict that UnitedHealth Group will post 12.53 EPS for the current fiscal year.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,655 shares of company stock worth $7,469,083. Company insiders own 0.89% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the business. Marshall Wace LLP boosted its holdings in UnitedHealth Group by 441.4% during the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after buying an additional 11,361 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after purchasing an additional 681,111 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares in the last quarter. Essex Financial Services Inc. lifted its holdings in shares of UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after purchasing an additional 967 shares in the last quarter. Finally, Bainco International Investors lifted its holdings in shares of UnitedHealth Group by 5.4% during the 3rd quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock valued at $16,192,000 after purchasing an additional 4,202 shares in the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2018/01/20/unitedhealth-group-unh-given-new-270-00-price-target-at-argus.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.